Table 3.
Heterosexual |
Lesbian |
χ2 |
pa |
Bisexual |
χ2 |
pa |
Lesbian |
Bisexual |
|
---|---|---|---|---|---|---|---|---|---|
Weighted % (95% CI) | Weighted % (95% CI) | aORb(95% CI) | aORb(95% CI) | ||||||
Heterosexual vs. lesbian | Heterosexual vs. bisexual | ||||||||
Tobacco use | 77.6 | <0.001 | 60.6 | <0.001 | |||||
Current smoker | 13.3 (12.9–13.7) | 21.3 (18.4–24.3) | 23.0 (19.9–26.1) | 2.34 (1.26–4.34) | 1.27 (0.68–2.39) | ||||
Former smoker | 18.9 (18.5–19.3) | 25.4 (22.3–28.5) | 18.2 (15.6–20.9) | 1.89 (1.21–2.96) | 1.82 (0.91–3.64) | ||||
Never smoker | 67.8 (67.3–68.3) | 53.2 (49.6–56.8) | 58.8 (55.3–62.4) | Ref. | Ref. | ||||
Heavy drinking | 6.5 (6.3–6.8) | 11.8 (9.5–14.1) | 85.2 | <0.001 | 13.4 (10.9–15.9) | 53.7 | <0.001 | 0.67 (0.27–1.66) | 2.06 (0.88–4.81) |
Binge drinking | 29.6 (29.0–30.3) | 43.6 (39.5–47.8) | 50.1 | <0.001 | 55.1 (50.7–59.6) | 146.2 | <0.001 | 1.45 (0.81–2.58) | 1.65 (0.96–2.84) |
Meeting physical activity guidelines | 33.7 (33.1–34.3) | 42.3 (38.8–45.7) | 25.5 | <0.001 | 44.9 (41.1–48.6) | 37.8 | <0.001 | 1.39 (0.85–2.26) | 0.93 (0.56–1.50) |
Preventive health care | |||||||||
Pap | 44.2 (43.7–44.8) | 41.1 (37.4–44.9) | 2.5 | 0.113 | 42.1 (38.1–46.1) | 1.1 | 0.293 | 0.56 (0.31–1.01) | 0.60 (0.31–1.56) |
Mammogram | 45.1 (44.5–45.7) | 44.8 (40.6–49.0) | 0.02 | 0.887 | 29.2 (24.4–34.0) | 34.6 | <0.001 | 1.06 (0.66–1.70) | 0.42 (0.23–0.78) |
Visit with ob/gyn | 39.6 (39.1–40.1) | 33.7 (30.5–36.9) | 12.3 | <0.001 | 42.0 (38.0–46.0) | 1.4 | 0.238 | 0.75 (0.45–1.24) | 0.81 (0.45–1.48) |
HPV vaccine | 13.6 (13.2–14.0) | 16.3 (13.0–19.5) | 3.0 | 0.084 | 38.0 (34.1–42.0) | 286.2 | <0.001 | 0.76 (0.15–3.92) | 0.80 (0.32–2.00) |
Significant (p ≤ 0.05) results are bolded. Heterosexual women serve as the reference group in all analyses. Regression models were adjusted for differences in age, race/ethnicity, education level, insurance type, cancer site (breast, gynecologic, and other), and survey year.
p Value for Rao-Scott Chi-square test for the difference.
Regression models estimate aORs using logistic and multinomial regression models.
HPV, human papillomavirus; ob/gyn, obstetrician/gynecologist.